Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Roy, KK; Sausville, EA
   Early development of cyclin dependent kinase modulators
   CURRENT PHARMACEUTICAL DESIGN
   
   K.K. Roy e E.A. Sausville, "Early development of cyclin dependent kinase modulators", CUR PHARM D, 7(16), 2001, pp. 1669-1687
2. Decker, RH; Dai, Y; Grant, S
   The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway
   CELL DEATH AND DIFFERENTIATION
   
   R.H. Decker et al., "The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway", CELL DEAT D, 8(7), 2001, pp. 715-724
3. Lademann, U; Kallunki, T; Jaattela, M
   A20 zinc finger protein inhibits TNF-induced apoptosis and stress responseearly in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins
   CELL DEATH AND DIFFERENTIATION
   
   U. Lademann et al., "A20 zinc finger protein inhibits TNF-induced apoptosis and stress responseearly in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins", CELL DEAT D, 8(3), 2001, pp. 265-272
4. Wang, CG; Fu, MF; Mani, S; Wadler, S; Senderowicz, AM; Pestell, RG
   Histone acetylation and the cell-cycle in cancer
   FRONTIERS IN BIOSCIENCE
   
   C.G. Wang et al., "Histone acetylation and the cell-cycle in cancer", FRONT BIOSC, 6, 2001, pp. D610-D629
5. Barcellos-Hoff, MH
   It takes a tissue to make a tumor: Epigenetics, cancer and the microenvironment
   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
   
   M.H. Barcellos-Hoff, "It takes a tissue to make a tumor: Epigenetics, cancer and the microenvironment", J MAMMARY G, 6(2), 2001, pp. 213-221
6. Rapoport, AP; Simons-Evelyn, M; Chen, T; Sidell, R; Luhowskyj, S; Rosell, K; Obrig, T; Hicks, D; Hinkle, PM; Nahm, M; Insel, RA; Abboud, CN
   Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes
   BLOOD CELLS MOLECULES AND DISEASES
   
   A.P. Rapoport et al., "Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes", BL CELL M D, 27(3), 2001, pp. 610-624
7. Jung, CP; Motwani, MV; Schwartz, GK
   Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotidereductase M2 subunit
   CLINICAL CANCER RESEARCH
   
   C.P. Jung et al., "Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotidereductase M2 subunit", CLIN CANC R, 7(8), 2001, pp. 2527-2536
8. Shapiro, GI; Supko, JG; Patterson, A; Lynch, C; Lucca, J; Zacarola, PF; Muzikansky, A; Wright, JJ; Lynch, TJ; Rollins, BJ
   A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer
   CLINICAL CANCER RESEARCH
   
   G.I. Shapiro et al., "A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer", CLIN CANC R, 7(6), 2001, pp. 1590-1599
9. Kawakami, K; Kawakami, M; Puri, RK
   Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy
   CRITICAL REVIEWS IN IMMUNOLOGY
   
   K. Kawakami et al., "Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy", CR R IMMUN, 21(1-3), 2001, pp. 299-310
10. Soni, R; Chaudhuri, B
    Cell cycle arrest mediated by a pyridopyrimidine is not abrogated by over-expression of Bcl-2 and cyclin D1
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    R. Soni e B. Chaudhuri, "Cell cycle arrest mediated by a pyridopyrimidine is not abrogated by over-expression of Bcl-2 and cyclin D1", INT J ONCOL, 18(5), 2001, pp. 1035-1040
11. Senderowicz, AM
    Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies
    LEUKEMIA
    
    A.M. Senderowicz, "Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies", LEUKEMIA, 15(1), 2001, pp. 1-9
12. Hughes, RC
    Galectins as modulators of cell adhesion
    BIOCHIMIE
    
    R.C. Hughes, "Galectins as modulators of cell adhesion", BIOCHIMIE, 83(7), 2001, pp. 667-676
13. Carloni, V; Mazzocca, A; Pantaleo, P; Cordella, C; Laffi, G; Gentilini, P
    The integrin, alpha 6 beta 1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells
    HEPATOLOGY
    
    V. Carloni et al., "The integrin, alpha 6 beta 1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells", HEPATOLOGY, 34(1), 2001, pp. 42-49
14. Kauppila, S; Jukkola, A; Melkko, J; Risteli, L; Turpeeniemi-Hujanen, T; Vuorinen, K; Risteli, J
    Aminoterminal propeptide of the alpha 1-homotrimer variant of human type Iprocollagen (hotPINP) in malignant pleural effusion
    ANTICANCER RESEARCH
    
    S. Kauppila et al., "Aminoterminal propeptide of the alpha 1-homotrimer variant of human type Iprocollagen (hotPINP) in malignant pleural effusion", ANTICANC R, 21(4A), 2001, pp. 2293-2296
15. Brockhoff, G; Heiss, P; Schlegel, J; Hofstaedter, F; Knuechel, R
    Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells
    CYTOMETRY
    
    G. Brockhoff et al., "Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells", CYTOMETRY, 44(4), 2001, pp. 338-348
16. Fukuoka, K; Usuda, J; Iwamoto, Y; Fukumoto, H; Nakamura, T; Yoneda, T; Narita, N; Saijo, N; Nishio, K
    Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells
    INVESTIGATIONAL NEW DRUGS
    
    K. Fukuoka et al., "Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells", INV NEW DR, 19(3), 2001, pp. 219-227
17. Hassan, P; Fergusson, D; Grant, KM; Mottram, JC
    The CRK3 protein kinase is essential for cell cycle progression of Leishmania Mexicana
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY
    
    P. Hassan et al., "The CRK3 protein kinase is essential for cell cycle progression of Leishmania Mexicana", MOL BIOCH P, 113(2), 2001, pp. 189-198
18. Rossini, GP; Sgarbi, N; Malaguti, C
    The toxic responses induced by okadaic acid involve processing of multiplecaspase isoforms
    TOXICON
    
    G.P. Rossini et al., "The toxic responses induced by okadaic acid involve processing of multiplecaspase isoforms", TOXICON, 39(6), 2001, pp. 763-770
19. Barcellos-Hoff, MH; Brooks, AL
    Extracellular signaling through the microenvironment: A hypothesis relating carcinogenesis, bystander effects, and genomic instability
    RADIATION RESEARCH
    
    M.H. Barcellos-Hoff e A.L. Brooks, "Extracellular signaling through the microenvironment: A hypothesis relating carcinogenesis, bystander effects, and genomic instability", RADIAT RES, 156(5), 2001, pp. 618-627
20. Wang, SY; Yang, KW; Hsu, YT; Chang, CL; Yang, YC
    The differential inhibitory effects of genistein on the growth of cervicalcancer cells in vitro
    NEOPLASMA
    
    S.Y. Wang et al., "The differential inhibitory effects of genistein on the growth of cervicalcancer cells in vitro", NEOPLASMA, 48(3), 2001, pp. 227-233
21. Medina, MA
    Glutamine and cancer
    JOURNAL OF NUTRITION
    
    M.A. Medina, "Glutamine and cancer", J NUTR, 131(9), 2001, pp. 2539S-2542S
22. Chakrabarty, S; Liu, BR; Rajagopal, S
    Disruption of transforming growth factor beta-regulated laminin receptor function by expression of antisense laminin, a chain RNA in human colon cancer cells
    JOURNAL OF CELLULAR PHYSIOLOGY
    
    S. Chakrabarty et al., "Disruption of transforming growth factor beta-regulated laminin receptor function by expression of antisense laminin, a chain RNA in human colon cancer cells", J CELL PHYS, 186(1), 2001, pp. 47-52
23. Seewaldt, VL; Mrozek, K; Sigle, R; Dietze, EC; Heine, K; Hockenbery, DM; Hobbs, KB; Caldwell, LE
    Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis
    JOURNAL OF CELL BIOLOGY
    
    V.L. Seewaldt et al., "Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis", J CELL BIOL, 155(3), 2001, pp. 471-486
24. Dow, R; Hendley, J; Pirkmaier, A; Musgrove, EA; Germain, D
    Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    R. Dow et al., "Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2", J BIOL CHEM, 276(49), 2001, pp. 45945-45951
25. Brodt, P; Fallavollita, L; Khatib, AM; Samani, AA; Zhang, DL
    Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    P. Brodt et al., "Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit", J BIOL CHEM, 276(36), 2001, pp. 33608-33615
26. Chao, SH; Price, DH
    Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.H. Chao e D.H. Price, "Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo", J BIOL CHEM, 276(34), 2001, pp. 31793-31799
27. Yoon, SO; Kim, MM; Chung, AS
    Inhibitory effect of selenite on invasion of HT1080 tumor cells
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.O. Yoon et al., "Inhibitory effect of selenite on invasion of HT1080 tumor cells", J BIOL CHEM, 276(23), 2001, pp. 20085-20092
28. Cottin, V; Van Linden, AA; Riches, DWH
    Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    V. Cottin et al., "Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis", J BIOL CHEM, 276(20), 2001, pp. 17252-17260
29. Li, WW; Fan, JG; Bertino, JR
    Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by ravopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity
    CANCER RESEARCH
    
    W.W. Li et al., "Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by ravopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity", CANCER RES, 61(6), 2001, pp. 2579-2582
30. Casagrande, F; Darbon, JM
    Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1
    BIOCHEMICAL PHARMACOLOGY
    
    F. Casagrande e J.M. Darbon, "Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1", BIOCH PHARM, 61(10), 2001, pp. 1205-1215
31. Kaubisch, A; Schwartz, GK
    Cyclin-dependent kinase and protein kinase C inhibitors: A novel class of antineoplastic agents in clinical development
    CANCER JOURNAL
    
    A. Kaubisch e G.K. Schwartz, "Cyclin-dependent kinase and protein kinase C inhibitors: A novel class of antineoplastic agents in clinical development", CANCER J, 6(4), 2000, pp. 192-212
32. Liu, FT
    Galectins: A new family of regulators of inflammation
    CLINICAL IMMUNOLOGY
    
    F.T. Liu, "Galectins: A new family of regulators of inflammation", CLIN IMMUNO, 97(2), 2000, pp. 79-88
33. Friedl, P; Brocker, EB
    The biology of cell locomotion within three-dimensional extracellular matrix
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    P. Friedl e E.B. Brocker, "The biology of cell locomotion within three-dimensional extracellular matrix", CELL MOL L, 57(1), 2000, pp. 41-64
34. Mani, S; Wang, CG; Wu, KM; Francis, R; Pestell, R
    Cyclin-dependent kinase inhibitors: novel anticancer agents
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    S. Mani et al., "Cyclin-dependent kinase inhibitors: novel anticancer agents", EXPERT OP I, 9(8), 2000, pp. 1849-1870
35. Kelland, LR
    Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    L.R. Kelland, "Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status", EXPERT OP I, 9(12), 2000, pp. 2903-2911
36. Manna, SK; Haridas, V; Aggarwal, BB
    Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappa B, activation protein-1, and c-Jun N-terminal kinase
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    S.K. Manna et al., "Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappa B, activation protein-1, and c-Jun N-terminal kinase", J INTERF CY, 20(8), 2000, pp. 725-735
37. Innocenti, F; Stadler, WM; Iyer, L; Ramirez, J; Vokes, EE; Ratain, MJ
    Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea
    CLINICAL CANCER RESEARCH
    
    F. Innocenti et al., "Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea", CLIN CANC R, 6(9), 2000, pp. 3400-3405
38. Ciardiello, F; Caputo, R; Bianco, R; Damiano, V; Pomatico, G; De Placido, S; Bianco, AR; Tortora, G
    Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor
    CLINICAL CANCER RESEARCH
    
    F. Ciardiello et al., "Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor", CLIN CANC R, 6(5), 2000, pp. 2053-2063
39. Green, DW; Roh, H; Pippin, J; Drebin, JA
    Antisense oligonucleotides: An evolving technology for the modulation of gene expression in human disease
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    
    D.W. Green et al., "Antisense oligonucleotides: An evolving technology for the modulation of gene expression in human disease", J AM COLL S, 191(1), 2000, pp. 93-105
40. Belkin, AM; Stepp, MA
    Integrins as receptors for laminins
    MICROSCOPY RESEARCH AND TECHNIQUE
    
    A.M. Belkin e M.A. Stepp, "Integrins as receptors for laminins", MICROSC RES, 51(3), 2000, pp. 280-301
41. Gescher, A
    Staurosporine analogues - pharmacological toys or useful antitumour agents?
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    A. Gescher, "Staurosporine analogues - pharmacological toys or useful antitumour agents?", CR R ONC H, 34(2), 2000, pp. 127-135
42. Li, YW; Chinni, SR; Senderowicz, AM; Sarkar, FH
    Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    Y.W. Li et al., "Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol", INT J ONCOL, 17(4), 2000, pp. 755-759
43. Owen-Schaub, L; Chan, H; Cusack, JC; Roth, J; Hill, LL
    Fas and Fas ligand interactions in malignant disease (Review)
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    L. Owen-Schaub et al., "Fas and Fas ligand interactions in malignant disease (Review)", INT J ONCOL, 17(1), 2000, pp. 5-12
44. Pallares-Trujillo, J; Lopez-Soriano, FJ; Argiles, JM
    Lipids: A key role in multidrug resistance? (Review)
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    J. Pallares-Trujillo et al., "Lipids: A key role in multidrug resistance? (Review)", INT J ONCOL, 16(4), 2000, pp. 783-798
45. Senderowicz, AM
    Small molecule modulators of cyclin-dependent kinases for cancer therapy
    ONCOGENE
    
    A.M. Senderowicz, "Small molecule modulators of cyclin-dependent kinases for cancer therapy", ONCOGENE, 19(56), 2000, pp. 6600-6606
46. Panigone, S; Debernardi, S; Taya, Y; Fontanella, E; Airoldi, R; Delia, D
    pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide
    ONCOGENE
    
    S. Panigone et al., "pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide", ONCOGENE, 19(35), 2000, pp. 4035-4041
47. Colic, M; Pavelic, K
    Molecular mechanisms of anticancer activity of natural dietetic products
    JOURNAL OF MOLECULAR MEDICINE-JMM
    
    M. Colic e K. Pavelic, "Molecular mechanisms of anticancer activity of natural dietetic products", J MOL MED-J, 78(6), 2000, pp. 333-336
48. Tsai, CM; Chang, KT; Li, L; Perng, RP; Yang, LY
    Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    C.M. Tsai et al., "Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells", JPN J CANC, 91(2), 2000, pp. 213-222
49. Jiang, C; Ganther, H; Lu, JX
    Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: Implications for angiogenic switch regulation
    MOLECULAR CARCINOGENESIS
    
    C. Jiang et al., "Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: Implications for angiogenic switch regulation", MOL CARCINO, 29(4), 2000, pp. 236-250
50. Stadler, WM; Vogelzang, NJ; Amato, R; Sosman, J; Taber, D; Liebowitz, D; Vokes, EE
    Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study
    JOURNAL OF CLINICAL ONCOLOGY
    
    W.M. Stadler et al., "Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study", J CL ONCOL, 18(2), 2000, pp. 371-375
51. Damiens, E; Meijer, L
    Chemical inhibitors of cyclin-dependent kinases: preclinical and clinical studies.
    PATHOLOGIE BIOLOGIE
    
    E. Damiens e L. Meijer, "Chemical inhibitors of cyclin-dependent kinases: preclinical and clinical studies.", PATH BIOL, 48(3), 2000, pp. 340-351
52. Lu, K; Shih, C; Teicher, BA
    Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    K. Lu et al., "Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents", CANC CHEMOT, 46(4), 2000, pp. 293-304
53. Liberto, M; Cobrinik, D
    Growth factor-dependent induction of p21(CIP1) by the green tea by polyphenol, epigallocatechin gallate
    CANCER LETTERS
    
    M. Liberto e D. Cobrinik, "Growth factor-dependent induction of p21(CIP1) by the green tea by polyphenol, epigallocatechin gallate", CANCER LETT, 154(2), 2000, pp. 151-161
54. Angelucci, A; D'Ascenzo, S; Festuccia, C; Gravina, GL; Bologna, M; Dolo, V; Pavan, A
    Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines
    CLINICAL & EXPERIMENTAL METASTASIS
    
    A. Angelucci et al., "Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines", CLIN EXP M, 18(2), 2000, pp. 163-170
55. Hyder, SM; Stancel, GM
    Regulation of VEGF in the reproductive tract by sex-steroid hormones
    HISTOLOGY AND HISTOPATHOLOGY
    
    S.M. Hyder e G.M. Stancel, "Regulation of VEGF in the reproductive tract by sex-steroid hormones", HIST HISTOP, 15(1), 2000, pp. 325-334
56. Albanese, J; Dainiak, N
    Ionizing radiation alters Fas antigen ligand at the cell surface and on exfoliated plasma membrane-derived vesicles: Implications for apoptosis and intercellular signaling
    RADIATION RESEARCH
    
    J. Albanese e N. Dainiak, "Ionizing radiation alters Fas antigen ligand at the cell surface and on exfoliated plasma membrane-derived vesicles: Implications for apoptosis and intercellular signaling", RADIAT RES, 153(1), 2000, pp. 49-61
57. Henriet, P; Zhong, ZD; Brooks, PC; Weinberg, KI; DeClerck, YA
    Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27(KIP1)
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    P. Henriet et al., "Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27(KIP1)", P NAS US, 97(18), 2000, pp. 10026-10031
58. Li, XK; Motwani, M; Tong, W; Bornmann, W; Schwartz, GK
    Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells
    MOLECULAR PHARMACOLOGY
    
    X.K. Li et al., "Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells", MOLEC PHARM, 58(6), 2000, pp. 1287-1293
59. Sielecki, TM; Boylan, JF; Benfield, PA; Trainor, GL
    Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation
    JOURNAL OF MEDICINAL CHEMISTRY
    
    T.M. Sielecki et al., "Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation", J MED CHEM, 43(1), 2000, pp. 1-18
60. Ram, TG; Hosick, HL; Ethier, SP
    Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells
    JOURNAL OF CELLULAR PHYSIOLOGY
    
    T.G. Ram et al., "Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells", J CELL PHYS, 183(3), 2000, pp. 301-313
61. Wagner, PD; Vu, ND
    Phosphorylation of geranyl and farnesyl pyrophosphates by Nm23 proteins/nucleoside diphosphate kinases
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    P.D. Wagner e N.D. Vu, "Phosphorylation of geranyl and farnesyl pyrophosphates by Nm23 proteins/nucleoside diphosphate kinases", J BIOL CHEM, 275(45), 2000, pp. 35570-35576
62. Chao, SH; Fujinaga, K; Marion, JE; Taube, R; Sausville, EA; Senderowicz, AM; Peterlin, BM; Price, DH
    Flavopiridol inhibits P-TEFb and blocks HIV-1 replication
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.H. Chao et al., "Flavopiridol inhibits P-TEFb and blocks HIV-1 replication", J BIOL CHEM, 275(37), 2000, pp. 28345-28348
63. Darbon, JM; Penary, M; Escalas, N; Casagrande, F; Goubin-Gramatica, F; Baudouin, C; Ducommun, B
    Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    J.M. Darbon et al., "Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells", J BIOL CHEM, 275(20), 2000, pp. 15363-15369
64. Fukuoka, K; Yamagishi, T; Ichihara, T; Nakaike, S; Iguchi, K; Yamada, Y; Fukumoto, H; Yoneda, T; Samata, K; Ikeya, H; Nanaumi, K; Hirayama, N; Narita, N; Saijo, N; Nishio, K
    Mechanism of action of aragusterol A (YTA0040), a potent anti-tumor marinesteroid targeting the G(1) phase of the cell cycle
    INTERNATIONAL JOURNAL OF CANCER
    
    K. Fukuoka et al., "Mechanism of action of aragusterol A (YTA0040), a potent anti-tumor marinesteroid targeting the G(1) phase of the cell cycle", INT J CANC, 88(5), 2000, pp. 810-819
65. Ferte, J
    Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    J. Ferte, "Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane", EUR J BIOCH, 267(2), 2000, pp. 277-294
66. Ciardiello, F
    Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents
    DRUGS
    
    F. Ciardiello, "Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents", DRUGS, 60, 2000, pp. 25-32
67. Kanai, T; Watanabe, M; Hayashi, A; Nakazawa, A; Yajima, T; Okazawa, A; Yamazaki, M; Ishii, H; Hibi, T
    Regulatory effect of interleukin-4 and interleukin-13 on colon cancer celladhesion
    BRITISH JOURNAL OF CANCER
    
    T. Kanai et al., "Regulatory effect of interleukin-4 and interleukin-13 on colon cancer celladhesion", BR J CANC, 82(10), 2000, pp. 1717-1723
68. Jiang, C; Agarwal, R; Lu, JX
    Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    C. Jiang et al., "Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells", BIOC BIOP R, 276(1), 2000, pp. 371-378
69. Senderowicz, AM; Sausville, EA
    Preclinical and clinical development of cyclin-dependent kinase modulators
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    A.M. Senderowicz e E.A. Sausville, "Preclinical and clinical development of cyclin-dependent kinase modulators", J NAT CANC, 92(5), 2000, pp. 376-387
70. Blanck, G
    HLA class II expression in human tumor lines
    MICROBES AND INFECTION
    
    G. Blanck, "HLA class II expression in human tumor lines", MICROBES IN, 1(11), 1999, pp. 913-918
71. Youn, J; Lynes, MA
    Metallothionein-induced suppression of cytotoxic T lymphocyte function: Animportant immunoregulatory control
    TOXICOLOGICAL SCIENCES
    
    J. Youn e M.A. Lynes, "Metallothionein-induced suppression of cytotoxic T lymphocyte function: Animportant immunoregulatory control", TOXICOL SCI, 52(2), 1999, pp. 199-208
72. Doman, RK; Perez, M; Donato, NJ
    JNK and p53 stress signaling cascades are altered in MCF-7 cells resistantto tumor necrosis factor-mediated apoptosis
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    R.K. Doman et al., "JNK and p53 stress signaling cascades are altered in MCF-7 cells resistantto tumor necrosis factor-mediated apoptosis", J INTERF CY, 19(3), 1999, pp. 261-269
73. Tsuruda, L; Hou, YT; Penning, T
    Stable transfection of dihydrodiol dehydrogenase in MCF-7 breast carcinomacells promotes polycyclic aromatic hydrocarbon-o-quinone formation which leads to cell death
    POLYCYCLIC AROMATIC COMPOUNDS
    
    L. Tsuruda et al., "Stable transfection of dihydrodiol dehydrogenase in MCF-7 breast carcinomacells promotes polycyclic aromatic hydrocarbon-o-quinone formation which leads to cell death", POLYCYCL AR, 16(1-4), 1999, pp. 215-224
74. Wen, XY; Stewart, AS; Sooknanan, RR; Henderson, G; Hawley, TS; Reimold, AM; Glimcher, LH; Baumann, H; Malek, LT; Hawley, RG
    Identification of c-myc promoter-binding protein and X-box binding proteinI as interleukin-6 target genes in human multiple myeloma cells.
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    X.Y. Wen et al., "Identification of c-myc promoter-binding protein and X-box binding proteinI as interleukin-6 target genes in human multiple myeloma cells.", INT J ONCOL, 15(1), 1999, pp. 173-178
75. Stimpfl, M; Schmid, BC; Obermair, A; Tong, D; Schiebel, I; Gitsch, G; Leodolter, S; Zeillinger, R
    Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood
    ONCOLOGY RESEARCH
    
    M. Stimpfl et al., "Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood", ONCOL RES, 11(8), 1999, pp. 367-373
76. Ito, K; Okamoto, I; Araki, N; Kawano, Y; Nakao, M; Fujiyama, S; Tomita, K; Mimori, T; Saya, H
    Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts
    ONCOGENE
    
    K. Ito et al., "Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts", ONCOGENE, 18(50), 1999, pp. 7080-7090
77. Rao, RN; Stamm, NB; Otto, K; Kovacevic, S; Watkins, SA; Rutherford, P; Lemke, S; Cocke, K; Beckmann, RP; Houck, K; Johnson, D; Skidmore, BJ
    Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene
    ONCOGENE
    
    R.N. Rao et al., "Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene", ONCOGENE, 18(46), 1999, pp. 6343-6356
78. Ameyar, M; Shatrov, V; Bouquet, C; Capoulade, C; Cai, ZZ; Stancou, R; Badie, C; Haddada, H; Chouaib, S
    Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb
    ONCOGENE
    
    M. Ameyar et al., "Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb", ONCOGENE, 18(39), 1999, pp. 5464-5472
79. Zhu, X; Pattenden, S; Bremner, R
    PRB is required for interferon-gamma-induction of the MHC class II A beta gene
    ONCOGENE
    
    X. Zhu et al., "PRB is required for interferon-gamma-induction of the MHC class II A beta gene", ONCOGENE, 18(35), 1999, pp. 4940-4947
80. Brakebusch, C; Wennerberg, K; Krell, HW; Weidle, UH; Sallmyr, A; Johansson, S; Fassler, R
    beta 1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts
    ONCOGENE
    
    C. Brakebusch et al., "beta 1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts", ONCOGENE, 18(26), 1999, pp. 3852-3861
81. Jiang, C; Jiang, WQ; Ip, C; Ganther, H; Lu, LX
    Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake
    MOLECULAR CARCINOGENESIS
    
    C. Jiang et al., "Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake", MOL CARCINO, 26(4), 1999, pp. 213-225
82. Martelli, AM; Sang, NL; Borgatti, P; Capitani, S; Neri, LM
    Multiple biological responses activated by nuclear protein kinase C
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    A.M. Martelli et al., "Multiple biological responses activated by nuclear protein kinase C", J CELL BIOC, 74(4), 1999, pp. 499-521
83. Chien, M; Astumian, M; Liebowitz, D; Rinker-Schaeffer, C; Stadler, WM
    In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    M. Chien et al., "In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer", CANC CHEMOT, 44(1), 1999, pp. 81-87
84. Jiang, SY; Lin, DY; Shyu, RY; Reichert, U; Yeh, MY
    The RAR gamma selective agonist CD437 inhibits gastric cell growth throughthe mechanism of apoptosis
    CANCER LETTERS
    
    S.Y. Jiang et al., "The RAR gamma selective agonist CD437 inhibits gastric cell growth throughthe mechanism of apoptosis", CANCER LETT, 137(2), 1999, pp. 217-225
85. Gopalakrishna, R; Gundimeda, U; Fontana, JA; Clarke, R
    Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status
    CANCER LETTERS
    
    R. Gopalakrishna et al., "Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status", CANCER LETT, 136(2), 1999, pp. 143-151
86. Ma, YJ; Hill, DF; Creswick, KE; Costa, ME; Cornea, A; Lioubin, MN; Plowman, GD; Ojeda, SR
    Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development
    JOURNAL OF NEUROSCIENCE
    
    Y.J. Ma et al., "Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development", J NEUROSC, 19(22), 1999, pp. 9913-9927
87. Sintich, SM; Steinberg, J; Kozlowski, JM; Lee, C; Pruden, S; Sayeed, S; Sensibar, JA
    Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin)
    PROSTATE
    
    S.M. Sintich et al., "Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin)", PROSTATE, 39(2), 1999, pp. 87-93
88. Dolo, V; D'Ascenzo, S; Violini, S; Pompucci, L; Festuccia, C; Ginestra, A; Vittorelli, ML; Canevari, S; Pavan, A
    Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
    CLINICAL & EXPERIMENTAL METASTASIS
    
    V. Dolo et al., "Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro", CLIN EXP M, 17(2), 1999, pp. 131-140
89. Kumeda, SI; Deguchi, A; Toi, M; Omura, S; Umezawa, K
    Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells
    ANTICANCER RESEARCH
    
    S.I. Kumeda et al., "Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells", ANTICANC R, 19(5B), 1999, pp. 3961-3968
90. Ginestra, A; Miceli, D; Dolo, V; Romano, FM; Vittorelli, ML
    Membrane vesicles in ovarian cancer fluids: A new potential marker
    ANTICANCER RESEARCH
    
    A. Ginestra et al., "Membrane vesicles in ovarian cancer fluids: A new potential marker", ANTICANC R, 19(4C), 1999, pp. 3439-3445
91. Shen, F; Xue, XJ; Weber, G
    Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells
    ANTICANCER RESEARCH
    
    F. Shen et al., "Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells", ANTICANC R, 19(3A), 1999, pp. 1657-1662
92. Han, JA; Park, SC
    Reduction of transglutaminase 2 expression is associated with an inductionof drug sensitivity in the PC-14 human lung cancer cell line
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    J.A. Han e S.C. Park, "Reduction of transglutaminase 2 expression is associated with an inductionof drug sensitivity in the PC-14 human lung cancer cell line", J CANC RES, 125(2), 1999, pp. 89-95
93. Oosterlaken-Dijksterhuis, MA; Kwant, MM; Slob, A; Hellmen, E; Mol, JA
    IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335
    BREAST CANCER RESEARCH AND TREATMENT
    
    M.A. Oosterlaken-Dijksterhuis et al., "IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335", BREAST CANC, 54(1), 1999, pp. 11-23
94. Otero, ADS; Doyle, MB; Hartsough, MT; Steeg, PS
    Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization ofmuscarinic potassium current
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    
    A.D.S. Otero et al., "Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization ofmuscarinic potassium current", BBA-MOL CEL, 1449(2), 1999, pp. 157-168
95. Sausville, EA; Zaharevitz, D; Gussio, R; Meijer, L; Louarn-Leost, M; Kunick, C; Schultz, R; Lahusen, T; Headlee, D; Stinson, S; Arbuck, SG; Senderowicz, A
    Cyclin-dependent kinases: Initial approaches to exploit a novel therapeutic target
    PHARMACOLOGY & THERAPEUTICS
    
    E.A. Sausville et al., "Cyclin-dependent kinases: Initial approaches to exploit a novel therapeutic target", PHARM THERA, 82(2-3), 1999, pp. 285-292
96. Go, V; Garey, J; Wolff, MS; Pogo, BGT
    Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line
    ENVIRONMENTAL HEALTH PERSPECTIVES
    
    V. Go et al., "Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line", ENVIR H PER, 107(3), 1999, pp. 173-177
97. Penichet, ML; Challita, PM; Shin, SU; Sampogna, SL; Rosenblatt, JD; Morrison, SL
    In vivo properties of three human HER2/neu-expressing murine cell lines inimmunocompetent mice
    LABORATORY ANIMAL SCIENCE
    
    M.L. Penichet et al., "In vivo properties of three human HER2/neu-expressing murine cell lines inimmunocompetent mice", LAB ANIM SC, 49(2), 1999, pp. 179-188
98. Shapiro, GI; Harper, JW
    Anticancer drug targets: cell cycle and checkpoint control
    JOURNAL OF CLINICAL INVESTIGATION
    
    G.I. Shapiro e J.W. Harper, "Anticancer drug targets: cell cycle and checkpoint control", J CLIN INV, 104(12), 1999, pp. 1645-1653
99. Klinowska, TCM; Soriano, JV; Edwards, GM; Oliver, JM; Valentijn, AJ; Montesano, R; Streuli, CH
    Laminin and beta 1 integrins are crucial for normal mammary gland development in the mouse
    DEVELOPMENTAL BIOLOGY
    
    T.C.M. Klinowska et al., "Laminin and beta 1 integrins are crucial for normal mammary gland development in the mouse", DEVELOP BIO, 215(1), 1999, pp. 13-32
100. Bjornland, K; Winberg, JO; Odegaard, OT; Hovig, E; Loennechen, T; Aasen, AO; Fodstad, O; Maelandsmo, GM
     S100A4 involvement in metastasis: Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme
     CANCER RESEARCH
     
     K. Bjornland et al., "S100A4 involvement in metastasis: Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme", CANCER RES, 59(18), 1999, pp. 4702-4708